We are live on ! Find out more
BNP Paribas Financial Markets

BNP Paribas Financial Markets Portfolio holdings

AUM $289B
1-Year Est. Return 60.46%
 

BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.

This Fund
S&P 500
This Quarter Est. Return
+11.81%
1 Year Est. Return
+60.46%
3 Year Est. Return
+148.24%
5 Year Est. Return
+163.86%
10 Year Est. Return
+570.16%
AUM
$137B
AUM Growth
-$343M
Cap. Flow
-$60.2B
Cap. Flow %
-43.91%
Top 10 Hldgs %
37.65%
Holding
4,298
New
1,712
Increased
503
Reduced
1,811
Closed
193

Sector Composition

Rank Sector Weight
1 Healthcare 26.55%
2 Technology 24.39%
3 Consumer Discretionary 8.23%
4 Materials 5.85%
5 Real Estate 5.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CADX
2676
DELISTED
CADENCE PHARMACEUTICALS, INC COM STK
CADX
$9.48K ﹤0.01%
1,048
-16,186
-94% -$117K
SEM
2677
DELISTED
Select Medical
SEM
$9.47K ﹤0.01%
1,514
-23,804
-94% -$116K
AMPE
2678
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$9.46K ﹤0.01%
+4
New +$9.46K
SMP icon
2679
Standard Motor Products
SMP
$863M
$9.46K ﹤0.01%
+257
New +$8.85K
FIO
2680
DELISTED
FUSION-IO INC COM
FIO
$9.45K ﹤0.01%
1,061
-835,834
-100% -$9.03M
ORIT
2681
DELISTED
Oritani Financial Corp. New
ORIT
$9.45K ﹤0.01%
589
-11,852
-95% -$191K
SLCA
2682
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
$9.45K ﹤0.01%
+277
New +$9.09K
CHCO icon
2683
City Holding Co
CHCO
$2.09B
$9.4K ﹤0.01%
+203
New +$9.33K
EVTC icon
2684
Evertec
EVTC
$1.9B
$9.39K ﹤0.01%
+381
New +$8.6K
LMNX
2685
DELISTED
Luminex Corp
LMNX
$9.39K ﹤0.01%
484
-9,812
-95% -$185K
PFPT
2686
DELISTED
Proofpoint, Inc.
PFPT
$9.39K ﹤0.01%
+283
New +$8.52K
ITG
2687
DELISTED
Investment Technology Group Inc
ITG
$9.38K ﹤0.01%
456
-9,770
-96% -$176K
FIX icon
2688
Comfort Systems
FIX
$62.2B
$9.33K ﹤0.01%
481
-9,656
-95% -$183K
STNR
2689
DELISTED
STEINER LEISURE LTD
STNR
$9.3K ﹤0.01%
189
-3,781
-95% -$214K
TUES
2690
DELISTED
Tuesday Morning Corp
TUES
$9.29K ﹤0.01%
582
-10,989
-95% -$156K
ACTG icon
2691
Acacia Research
ACTG
$442M
$9.28K ﹤0.01%
638
-12,902
-95% -$204K
DXM
2692
DELISTED
DEX MEDIA INC NEW COM STK (DE)
DXM
$9.27K ﹤0.01%
+1,367
New +$8.61K
BLT
2693
DELISTED
BLOUNT INTERNATIONAL (NEW)
BLT
$9.23K ﹤0.01%
638
-12,750
-95% -$169K
GBDC icon
2694
Golub Capital BDC
GBDC
$3.46B
$9.23K ﹤0.01%
+493
New +$8.58K
TG icon
2695
Tredegar Corp
TG
$277M
$9.19K ﹤0.01%
+319
New +$8.52K
ACTA
2696
DELISTED
Actua Corp
ACTA
$9.19K ﹤0.01%
493
-9,831
-95% -$166K
ACET
2697
DELISTED
Aceto Corp
ACET
$9.18K ﹤0.01%
+367
New +$7.04K
ELLI
2698
DELISTED
Ellie Mae Inc
ELLI
$9.16K ﹤0.01%
341
-6,883
-95% -$194K
EBS icon
2699
Emergent Biosolutions
EBS
$229M
$9.15K ﹤0.01%
+398
New +$8.3K
NEWP
2700
DELISTED
NEWPORT CORP
NEWP
$9.14K ﹤0.01%
506
-9,804
-95% -$160K

Similar funds

BNP Paribas Financial Markets's Q4 2013 Portfolio in Review

As of Q4 2013, BNP Paribas Financial Markets held 4,298 positions worth $137B, down 0.25% from $137B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

BNP Paribas Financial Markets withdrew a net $60.2B in Q4 2013, closing 193 positions and reducing 1,811 holdings. Its most notable exit was Innoviva, an estimated $182M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 17% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, BNP Paribas Financial Markets opened a new position in Ambev worth $22.5M.

  • BNP Paribas Financial Markets's largest Q4 2013 buy was Ambev: 3,066,560 shares worth $22.5M.
  • BNP Paribas Financial Markets added most to Apple in Q4 2013, an estimated $156M increase.
  • BNP Paribas Financial Markets's biggest Q4 2013 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.53B.
  • BNP Paribas Financial Markets fully exited Innoviva in Q4 2013, selling an estimated $182M.
  • BNP Paribas Financial Markets's ten largest holdings make up 38% of its $137B portfolio in Q4 2013.
  • BNP Paribas Financial Markets opened 1,712 new positions and closed 193 in Q4 2013.
  • BNP Paribas Financial Markets's portfolio value fell 0.25% quarter-over-quarter to $137B.

Based on BNP Paribas Financial Markets's 13F filing for Q4 2013, filed 12 Feb 2014.